Showing results (341-350 of 526) with videos related to
Sort By:
Pageof 53
Pediatric Blood & Cancer|March 31, 2021
Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregiversKalene van Engelen, Maru Barrera, Jonathan D Wasserman, et al.Prenatal Diagnosis|July 10, 2026
Natural History of Fetal Non-Nuchal Lymphatic Malformations: A Single Center Retrospective StudyYada Kunpalin, Dilkash Kajal, Lennart Van der Veeken, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 10, 2017
Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort studyChristel Tran, Jaina Patel, Hewson Stacy, et al.Cancer Biology & Therapy|December 2, 2011
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohortRobert K Nam, William Zhang, Katherine Siminovitch, et al.The Journal of Urology|May 15, 2018
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 YearsHanan Goldberg, Zachary Klaassen, Thenappan Chandrasekar, et al.Journal of the American Heart Association|June 4, 2013
Impact of prenatal risk factors on congenital heart disease in the current eraAlan Fung, Cedric Manlhiot, Sapna Naik, et al.Journal of Pediatric Genetics|August 15, 2018
Challenges in Diagnosing Rare Genetic Causes of Common In Utero Presentations: Report of Two Patients with Mucolipidosis Type II (I-Cell Disease)Gregory Costain, Michal Inbar-Feigenberg, Maha Saleh, et al.American Journal of Medical Genetics. Part A|July 9, 2011
Duplication of the STS region in males is a benign copy-number variantAubry Furrow, Aaron Theisen, Lea Velsher, et al.Prenatal Diagnosis|January 27, 2024
Validation of low-pass genome sequencing for prenatal diagnosisChloe Mighton, Abdul Noor, Nicholas Watkins, et al.European Urology|May 14, 2013
A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progressionLih-Ming Wong, Shabbir M H Alibhai, Greg Trottier, et al.Pageof 53